Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2008

Oct 24, 2008

30718_dirs_2008-10-24_dc54bc10-8aba-4584-8650-c72fb3d9a9bc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2008-10-23

Reporting Person: HOLBROOK KAREN A (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2008-10-23 Director Stock Option $65.47 A 5000 Acquired 2018-10-22 Common Stock (5000) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Director Stock Option $66.59 2017-10-24 Common Stock (5000) 5000 Direct
Director Stock Option $57.06 2017-02-11 Common Stock (10000) 10000 Direct

Footnotes

F1: 5000 exercisable 2/12/07. 5000 exercisable 2/12/08